Results from the PROfound phase III study, funded by AstraZeneca and Merck Sharp & Dohme, open up a much-needed new…
First results from the CheckMate 9ER phase III trial point to practice-changing data for the first-line treatment of patients with…
The results of two studies that have just been presented at the Congress of the European Society for Medical Oncology…
The newly-formed spin-off is led by Aleix Prat, from Hospital Clinic-IDIBAPS and the University of Barcelona (UB), together with Ana…
It has done so within the framework of the last congress of the European Society for Medical Oncology (ESMO). Barcelona,…
Barcelona, September 16, 2020.- Launched back in 2016 by Spanish Association against Cancer (AECC), and organized in collaboration with the Spanish…
Barcelona, September 10, 2020.- The countdown is now on as we all look forward to participating at ESMO’s Virtual Congress 2020,…
Barcelona, September 2, 2020.- Led by Fernanda Mosele, Goustave Roussy (Villejuif, France), an international group of leading experts, including VHIO’s…
Barcelona, August 14, 2020.- Two VHIO-led projects have been selected by the national Agency for Management of University and Research…
Barcelona. August 6, 2020.- Published ahead of print as an open access as Special Article* in Annals of Oncology, the…
In an online interview, published yesterday by leading oncology channel ecancer, Joaquin Mateo, Principal Investigator of VHIO’s Prostate Cancer Translational…
Barcelona, August 4, 2020.- First authored by Anton Berns, The Netherlands Cancer Institute (NKI), who -like many of the co-authors- is…
